Lenacapavir

CAS No. 2189684-44-2

Lenacapavir( GS-6207 )

Catalog No. M26233 CAS No. 2189684-44-2

Lenacapavir is a potent capsid-targeting inhibitor of HIV replication. Lenacapavir shows anti-HIV activity with an EC50 of 100 pM in MT-4 cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 616 In Stock
5MG 376 In Stock
10MG 565 In Stock
25MG 998 In Stock
50MG 1358 In Stock
100MG 1841 In Stock
200MG 2567 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Lenacapavir
  • Note
    Research use only, not for human use.
  • Brief Description
    Lenacapavir is a potent capsid-targeting inhibitor of HIV replication. Lenacapavir shows anti-HIV activity with an EC50 of 100 pM in MT-4 cells.
  • Description
    Lenacapavir is a potent capsid-targeting inhibitor of HIV replication. Lenacapavir shows anti-HIV activity with an EC50 of 100 pM in MT-4 cells.(In Vitro):Lenacapavir displays a mean EC50 of 50 pM (20-160 pM) against 23 HIV-1 clinical isolates from different subtypes in peripheral blood mononuclear cells. Lenacapavir shows sub-nanomolar potency in target cells with EC50 of 23 pM, in a full-cycle assay with EC50 of 25 pM and in producer cells with EC50 of 439 pM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    GS-6207
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2189684-44-2
  • Formula Weight
    968.28
  • Molecular Formula
    C39H32ClF10N7O5S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 200 mg/mL (206.55 mM)
  • SMILES
    [H][C@]12C[C@@]1([H])C(F)(F)c1c2c(nn1CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)c1nc(ccc1-c1ccc(Cl)c2c(NS(C)(=O)=O)nn(CC(F)(F)F)c12)C#CC(C)(C)S(C)(=O)=O)C(F)(F)F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tagliabue A, Rappuoli R. Vaccine adjuvants:the dream becomes real. Hum Vaccin. 2008 Sep-Oct;4(5):347-9.
molnova catalog
related products
  • Teneligliptin hydrob...

    Teneligliptin is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor; competitively inhibited human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50 values of approximately 1 nM.

  • SP1

    SP1

  • [Tyr11] Somatostatin

    [Tyr11] Somatostatin